International Society for the Study of Vascular Anomalies
Newsletter Vol 7 - No 2 | March 2023
ISSVA President's Message
We look forward to seeing you at our upcoming Debates & Updates meeting in April. I have been impressed with the teamwork involved in preparation for this meeting, which I am certain will be interactive and energizing. Please note the following:
ISSVA Classification Update:
- ISSVA members will receive an email this week with a copy of the suggested updates. Please review the documents. We are requesting your input during this public commentary period (ending 04/16/2023). Further discussions will ensue on Wednesday, 19 April 2023 9:00-10:00 am, "Classification," moderated by Dr. Ilona Frieden and Dr. Tony Penington at the Boston meeting.
Pre-meeting Surveys:
- There will be 2 pre-meeting surveys: one for ISSVA members and registrants and one for Patient Advocacy Groups
- Please complete these surveys PRIOR to the Boston meeting (deadlines for response will be included with the survey links), as the information received will be presented during the meeting.
Thank you to the many individuals who have participated in the meeting preparation. We look forward to seeing you all in Boston. Safe travels!
Respectfully,
Francine Blei
Journal of Vascular Anomalies (JoVA)
The Journal of Vascular Anomalies (JoVA) has been approved by the Directory of Open Access Journals (DOAJ). This was the first and significant hurdle to become Pubmed Central indexed, the Medline arm for Open Access journals. In a separate process, JoVA is applying for the all-important Impact Factor. Thus, JoVA is on the road toward increased discoverability through literature indexing as planned. Don’t forget, all prior publications in JoVA with be retroactively placed in Pubmed Central once JoVA is accepted.
Today, we have approximately 80 high-quality articles covering basic science, clinical series, evidence-based reviews, contemporary reviews, case reports, and "how-I-do-it" pieces. Over 100 reviewers, and an amazing editorial team, diligently and efficiently completed their work to get authors published in a timely fashion. On average, manuscript reviews were completed by 10.5 days with a turn-around response time to authors in 39 days, and a final article disposition by 65 days.
Again, thank you! Member support of JoVA has rendered its success as the official journal of the International Society for the Study of Vascular Anomalies (ISSVA) and the only journal of its kind dedicated to the complex world of Vascular Anomalies. Please continue to encourage your colleagues and thought leaders to submit their original articles, reviews, and cases to JoVA today. As you know, our continued success depends upon the volume and quality of manuscript submissions received. Also, look toward JoVA in coming months to find 2022's ISSVA World Congress compendium of abstracts.
We invite you to read some of JoVA's most recent publications:
- Plasma Cell-Free DNA After Embolization: A Novel, Sensitive Method for the Molecular Diagnosis of Venous Malformations
Sun, Yi; Cai, Ren; Wang, Zhenfeng; Wang, Deming; Zhao, Xiong; Yue, Xiaojie; Gu, Hao; Shi, Hao; Liu, Yun; Fan, Xindong; Su, Lixi - Sirolimus Early Treatment in Vascular Anomalies Leads to a Better Response
Triana, Paloma; Díez-Sebastián, Jesús; Rodriguez-Laguna, Lara; Martinez-Glez, Victor; Lopez-Gutierrez, Juan Carlos - MAP2K1 Mutation in Zebrafish Endothelial Cells Causes Arteriovenous Shunts Preventable by MEK Inhibition
Sudduth, Christopher L.; Blum, Nicola; Smits, Patrick J.; Cheng, Yu Sheng; Vivero, Matthew P.; Harris, Matthew P.; Lawson, Nathan D.; Greene, Arin K. - A Dynamic Web-based Application for the Classification of Vascular Anomalies
Taghinia, Aiden S.; Balkin, Daniel M.
Submit today to ISSVA’s journal dedicated to Vascular Anomalies. Expedited review and publication! ISSVA members get discounted open access publication fee of only $250.
ISSVA "Debates & Updates" 2023 (Boston)
Registration is open for our "Debates & Updates" Meeting in Boston, United States 19-21 April 2023. This meeting will be held in a hybrid format so we welcome both in-person and virtual attendees. However, in-person attendance is limited so we encourage you to register soon if you plan to attend in-person.
If you register to attend in-person, please also be sure to book your hotel room since there is limited hotel room availability.
Attendees: Please look out for pre-meeting surveys to obtain feedback on the direction of ISSVA and other information.
Membership Corner
Classification Comments from Membership: The ISSVA Classification Task Force has completed their review to address updates since the 2018 publication of the ISSVA Classification. The 2023 Classification update will open soon for membership comments. All comments will be due by 16 April in order to be discussed during the Pre-Congress Classification session during ISSVA 2023 Debates & Updates.
Message Boards: Read the latest messages or start a conversation online with other members - ISSVA Message Boards.
Social Media: Follow ISSVA on Twitter @ISSVA_org
In Memoriam
ISSVA extends our thoughts to the family and friends of Dr. Jennifer Marler, who sadly passed away earlier this month. Read Dr. Marler's obituary.
World of Vascular Anomalies
ISSVA believes it's important to unite the vascular anomalies community so we share with you, our members, the below events and changes in the field that are not organized or associated with ISSVA, but may be of interest to you. Please note that the events and news items listed below do not indicate an endorsement or sponsorship of these events by ISSVA.
Educational Opportunities
PIK3CA-related overgrowth spectrum (PROS): Updates & advances in MDT care
UCL Great Ormond Street Institute of Child Health
30 Guilford Street London
WC1N 1EH United Kingdom
24 April, 2023
Learn More
Are we missing any meetings or items of interest?
If you are aware of an upcoming educational opportunity, meeting or other item of interest that should be included, please let us know at info@issva.org so we can review the item and, if appropriate, share it with our membership in our next newsletter.